Neuroimaging and neurologic complications after organ transplantation

Journal of Neuroimaging

Volumn 17, Issue 2, 2007, Pages 110-123

  Živković, Saša ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Central pontine myelinolysis; Immunosuppression; Neuroimaging; Neurologic complications; Opportunistic infections; Organ transplantation; Posterior reversible encephalopathy syndrome

Indexed keywords

CYCLOSPORIN; OKT 3; TACROLIMUS;

ABSCESS; AMEBIASIS; BACTERIAL MENINGITIS; BRAIN DISEASE; BRAIN HEMORRHAGE; BRAIN TUMOR; BRAIN VASCULITIS; CENTRAL PONTINE MYELINOLYSIS; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; COCCIDIOIDOMYCOSIS; COMPUTER ASSISTED TOMOGRAPHY; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DISKITIS; HEMATOLOGIC DISEASE; HUMAN; LIPOMATOSIS; LIVER FAILURE; MENINGOENCEPHALITIS; MUCORMYCOSIS; MYCOBACTERIUM TUBERCULOSIS; NEUROIMAGING; NEUROLOGICAL COMPLICATION; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPPORTUNISTIC INFECTION; ORGAN TRANSPLANTATION; OSTEOMYELITIS; PATHOPHYSIOLOGY; POSTERIOR REVERSIBLE LEUKOENCEPHALOPATHY; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMIC MYCOSIS; TOXOPLASMOSIS; TREATMENT RESPONSE; VIRUS ENCEPHALITIS; VIRUS INFECTION; WERNICKE ENCEPHALOPATHY;

DIAGNOSTIC IMAGING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NERVOUS SYSTEM DISEASES; OPPORTUNISTIC INFECTIONS; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS;

EID: 34247251990     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2007.00097.x     Document Type: Review

References (106)

1. Patchell RA. Neurological complications of organ transplantation. Ann Neurol 1994;36(5):688-703.
2. Bronster DJ, Emre S, Boccagni P, Sheiner PA, Schwartz ME, Miller CM. Central nervous system complications in liver transplant recipients-incidence, timing, and longterm follow-up. Clin Transplant 2000;14(1):1-7.
3. Pless M, Zivkovic SA. Neurologic complications of transplantation. Neurologist 2002;8(2):107-120.
4. Guarino M, Benito-Leon J, Decruyenaere J, Schmutzhard E, Weissenborn K, Stracciari A. EFNS guidelines on management of neurological problems in liver transplantation. Eur J Neurol 2006;13(1):2-9.
5. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998;338(24):1741-1751.
6. Yuh WT, Nguyen HD, Gao F, et al. Brain parenchymal infection in bone marrow transplantation patients: CT and MR findings. AJR Am J Roentgenol 1994;162(2):425-430.
7. Kuker W, Nagele T, Schmidt F, Heckl S, Herrlinger U. Diffusion-weighted MRI in herpes simplex encephalitis: a report of three cases. Neuroradiology 2004;46(2):122-125.
8. Bollen AE, Wartan AN, Krikke AP, Haaxma-Reiche H. Amnestic syndrome after lung transplantation by human herpes virus-6 encephalitis. J Neurol 2001;248(7):619-620.
9. Singh N, Paterson DL. Encephalitis caused by human herpesvirus-6 in transplant recipients: relevance of a novel neurotropic virus. Transplantation 2000;69(12):2474-2479.
10. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000;342(9):635-645.
11. Tauro S, Toh V, Osman H, Mahendra P. Varicella zoster meningoencephalitis following treatment for dermatomal zoster in an alloBMT patient. Bone Marrow Transplant 2000;26(7):795-796.
12. Zeiser R, Grullich C, Bertz H, et al. Late cytomegalovirus polyradiculopathy following haploidentical CD34+-selected hematopoietic stem cell transplantation. Bone Marrow Transplant 2004;33(2):243-245.
13. Arata MA, Provenzale JM, Vredenburgh JJ. Cytomegalovirus encephalomyelitis: MR imaging findings documenting response to ganciclovir therapy. AJR Am J Roentgenol 1998;171(1):103-105.
14. Majid A, Galetta SL, Sweeney CJ, et al. Epstein-Barr virus myeloradiculitis and encephalomyeloradiculitis. Brain 2002;125(Pt 1):159-165.
15. DeBiasi RL, Tyler KL. West Nile virus meningoencephalitis. Nature Clin Pract Neurol 2006;2(5):264-275.
16. DeSalvo D, Roy-Chaudhury P, Peddi R, et al. West Nile virus encephalitis in organ transplant recipients: another high-risk group for meningoencephalitis and death. Transplantation 2004;77(3):466-469.
17. Iwamoto M, Jernigan DB, Guasch A, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003;348(22):2196-2203.
18. Kleinschmidt-DeMasters BK, Marder BA, Levi ME, et al. Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. Arch Neurol 2004;61(8):1210-1220.
19. Srinivasan A, Burton EC, Kuehnert MJ, et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005;352(11):1103-1111.
20. Burton EC, Burns DK, Opatowsky MJ, et al. Rabies encephalomyelitis: clinical, neuroradiological, and pathological findings in 4 transplant recipients. Arch Neurol 2005;62(6):873-882.
21. Shitrit D, Lev N, Bar-Gil-Shitrit A, Kramer MR. Progressive multifocal leukoencephalopathy in transplant recipients. Transpl Int 2005;17(11):658-665.
22. Bronster DJ, Lidov MW, Wolfe D, Schwartz ME, Miller CM. Progressive multifocal leukoencephalopathy after orthotopic liver transplantation. Liver Transpl Surg 1995;1(6):371-372.
23. Mader I, Herrlinger U, Klose U, Schmidt F, Kuker W. Progressive multifocal leukoencephalopathy: analysis of lesion development with diffusion-weighted MRI. Neuroradiology 2003;45(10):717-721.
24. Kuker W, Mader I, Nagele T, et al. Progressive multifocal leukoencephalopathy: value of diffusion-weighted and contrast-enhanced magnetic resonance imaging for diagnosis and treatment control. Eur J Neurol 2006;13(8):819-826.
25. Mamelak AN, Obana WG, Flaherty JF, Rosenblum ML. Nocardial brain abscess: treatment strategies and factors influencing outcome. Neurosurgery 1994;35(4):622-631.
26. Martino R, Martinez C, Brunet S, Sureda A, Lopez R, Domingo-Albos A. Tuberculosis in bone marrow transplant recipients: report of two cases and review of the literature. Bone Marrow Transplant 1996;18(4):809-812.
27. Nadal Desbarats L, Herlidou S, de Marco G, et al. Differential MRI diagnosis between brain abscesses and necrotic or cystic brain tumors using the apparent diffusion coefficient and normalized diffusion-weighted images. Magn Reson Imaging 2003;21(6):645-650.
28. Mishra AM, Gupta RK, Jaggi RS, et al. Role of diffusion-weighted imaging and in vivo proton magnetic resonance spectroscopy in the differential diagnosis of ring-enhancing intracranial cystic mass lesions. J Comput Assist Tomogr 2004;28(4):540-547.
29. Singh N, Avery RK, Munoz P, et al. Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis 2003;36(1):46-52.
30. Miaux Y, Ribaud P, Williams M, et al. MR of cerebral aspergillosis in patients who have had bone marrow transplantation. AJNR Am J Neuroradiol 1995;16(3):555-562.
31. Guermazi A, Gluckman E, Tabti B, Miaux Y. Invasive central nervous system aspergillosis in bone marrow transplantation recipients: an overview. Eur Radiol 2003;13(2):377-388.
32. Ashdown BC, Tien RD, Felsberg GJ. Aspergillosis of the brain and paranasal sinuses in immunocompromised patients: CT and MR imaging findings. AJR Am J Roentgenol 1994;162(1):155-159.
33. Hurst RW, Judkins A, Bolger W, Chu A, Loevner LA. Mycotic aneurysm and cerebral infarction resulting from fungal sinusitis: imaging and pathologic correlation. AJNR Am J Neuroradiol 2001;22(5):858-863.
34. Christophe C, Azzi N, Bouche B, Dan B, Levivier M, Ferster A. Magnetic resonance imaging and angiography in cerebral fungal vasculitis. Neuropediatrics 1999;30(4):218-220.
35. Wu G, Vilchez RA, Eidelman B, Fung J, Kormos R, Kusne S. Cryptococcal meningitis: an analysis among 5,521 consecutive organ transplant recipients. Transpl Infect Dis 2002;4(4):183-188.
36. Hagensee ME, Bauwens JE, Kjos B, Bowden RA. Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992. Clin Infect Dis 1994;19(3):402-408.
37. Erly WK, Bellon RJ, Seeger JF, Carmody RF. MR imaging of acute coccidioidal meningitis. AJNR Am J Neuroradiol 1999;20(3):509-514.
38. Kotton CN, Marconi VC, Fishman JA, Chung RT, Elias N, Hertl M. Coccidioidal meningitis after liver transplantation in a nonendemic region: a case report. Transplantation 2006;81(1):132-134.
39. McLean FM, Ginsberg LE, Stanton CA. Perineural spread of rhinocerebral mucormycosis. AJNR Am J Neuroradiol 1996;17(1):114-116.
40. Yoon JH, Na DG, Byun HS, Koh YH, Chung SK, Dong HJ. Calcification in chronic maxillary sinusitis: comparison of CT findings with histopathologic results. AJNR Am J Neuroradiol 1999;20(4):571-574.
41. Som PM, Dillon WP, Fullerton GD, Zimmerman RA, Rajagopalan B, Marom Z. Chronically obstructed sinonasal secretions: observations on T1 and T2 shortening. Radiology 1989;172(2):515-520.
42. de Medeiros CR, Bleggi-Torres LF, Faoro LN, et al. Cavernous sinus thrombosis caused by zygomycosis after unrelated bone marrow transplantation. Transpl Infect Dis 2001;3(4):231-234.
43. Selby R, Ramirez CB, Singh R, et al. Brain abscess in solid organ transplant recipients receiving cyclosporine-based immunosuppression. Arch Surg 1997;132(3):304-310.
44. Dietrich U, Maschke M, Dorfler A, Prumbaum M, Forsting M. MRI of intracranial toxoplasmosis after bone marrow transplantation. Neuroradiology 2000;42(1):14-18.
45. Chong-Han CH, Cortez SC, Tung GA. Diffusion-weighted MRI of cerebral toxoplasma abscess. AJR Am J Roentgenol 2003;181(6):1711-1714.
46. Kidney DD, Kim SH. CNS infections with free-living amebas: neuroimaging findings. AJR Am J Roentgenol 1998;171(3):809-812.
47. Mendez O, Kanal E, Abu-Elmagd KM, McFadden K, Thomas S, Bond G, et al. Granulomatous amebic encephalitis in a multivisceral transplant recipient. Eur J Neurol 2006;13(3):292-295.
48. Williams RL, Fukui MB, Meltzer CC, Swarnkar A, Johnson DW, Welch W. Fungal spinal osteomyelitis in the immunocompromised patient: MR findings in three cases. AJNR Am J Neuroradiol 1999;20(3):381-385.
49. Finelli PF, Uphoff DF. Magnetic resonance imaging abnormalities with septic encephalopathy. J Neurol Neurosurg Psychiatry 2004;75(8):1189- 1191.
50. Wijdicks EF. Neurotoxicity of immunosuppressive drugs. Liver Transpl 2001;7(11):937-942.
51. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334(8):494-500.
52. Small SL, Fukui MB, Bramblett GT, Eidelman BH. Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506). Ann Neurol 1996;40(4):575-580.
53. Lamy C, Oppenheim C, Meder JF, Mas JL. Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging 2004;14(2):89-96.
54. Bakshi R, Bates VE, Mechtler LL, Kinkel PR, Kinkel WR. Occipital lobe seizures as the major clinical manifestation of reversible posterior leukoencephalopathy syndrome: magnetic resonance imaging findings. Epilepsia 1998;39(3):295-299.
55. Reinohs M, Straube T, Baum P, Berrouschot J, Wagner A. Recurrent reversible cerebral edema after long term immunosuppression with tacrolimus. J Neurol 2002;249(6):780-781.
56. Chtioui H, Zimmermann A, Dufour JF. Unusual evolution of posterior reversible encephalopathy syndrome (PRES) one year after liver transplantation. Liver Transpl 2005;11(5):588-590.
57. Oliverio PJ, Restrepo L, Mitchell SA, Tornatore CS, Frankel SR. Reversible tacrolimus-induced neurotoxicity isolated to the brain stem. AJNR Am J Neuroradiol 2000;21(7):1251-1254.
58. Lorberboym M, Bronster DJ, Lidov M, Pandit N. Reversible cerebral perfusion abnormalities associated with cyclosporine therapy in orthotopic liver transplantation. J Nucl Med 1996;37(3):467-469.
59. Eidelman BH, Abu-Elmagd K, Wilson J, et al. Neurologic complications of FK 506. Transplant Proc 1991;23(6):3175-3178.
60. Singh N, Bonham A, Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation 2000;69(4):467-472.
61. Boeve BF, Kimmel DW, Aronson AE, de Groen PC. Dysarthria and apraxia of speech associated with FK-506 (tacrolimus). Mayo Clin Proc 1996;71(10):969-972.
62. Valldeoriola F, Graus F, Rimola A, et al. Cyclosporine-associated mutism in liver transplant patients. Neurology 1996;46(1):252-254.
63. Bronster DJ, Gurkan A, Buchsbaum MS, Emre S. Tacrolimus-associated mutism after orthotopic liver transplantation. Transplantation 2000;70(6):979-982.
64. Eidelman BH, Pulipaka U, Wiley C, Charron M, Bohnen NI. Abnormal cerebral blood flow findings in transplant patients with posttransplant apraxia of speech. Transplant Proc 2001;33(4):2563-2565.
65. Lavigne CM, Shrier DA, Ketkar M, Powers JM. Tacrolimus leukoencephalopathy: a neuropathologic confirmation. Neurology 2004;63(6):1132-1133.
66. Au WY, Lie AK, Lam CC, et al. Tacrolimus (FK 506) induced thrombotic thrombocytopenic purpura after ABO mismatched second liver transplantation: salvage with plasmapheresis and prostacyclin. Haematologica 2000;85(6):659-662.
67. Pittock SJ, Rabinstein AA, Edwards BS, Wijdicks EF. OKT3 neurotoxicity presenting as akinetic mutism. Transplantation 2003;75(7):1058-1060.
68. Parizel PM, Snoeck HW, van den Hauwe L, et al. Cerebral complications of murine monoclonal CD3 antibody (OKT3): CT and MR findings. AJNR Am J Neuroradiol 1997;18(10):1935-1938.
69. Hierholzer J, Benndorf G, Lehmann T, et al. Epidural lipomatosis: case report and literature review. Neuroradiology 1996;38(4):343-348.
70. Sila CA. Spectrum of neurologic events following cardiac transplantation. Stroke 1989;20(11):1586-1589.
71. Coplin WM, Cochran MS, Levine SR, Crawford SW. Stroke after bone marrow transplantation: frequency, aetiology and outcome. Brain 2001;124(Pt 5):1043-1051.
72. Nankivell BJ, Lau SG, Chapman JR, O'Connell PJ, Fletcher JP, Allen RD. Progression of macrovascular disease after transplantation. Transplantation 2000;69(4):574-581.
73. Massaro AR, Dutra AP, Almeida DR, Diniz RV, Malheiros SM. Transcranial Doppler assessment of cerebral blood flow: effect of cardiac transplantation. Neurology 2006;66(1):124-126.
74. Adair JC, Call GK, O'Connell JB, Baringer JR. Cerebrovascular syndromes following cardiac transplantation. Neurology 1992;42(4):819-823.
75. Eidelman BH, Obrist WD, Wagner WR, Kormos R, Griffith B. Cerebrovascular complications associated with the use of artificial circulatory support services. Neurol Clin 1993;11(2):463-474.
76. Oliveras A, Roquer J, Puig JM, et al. Stroke in renal transplant recipients: epidemiology, predictive risk factors and outcome. Clin Transplant 2003;17(1):1-8.
77. Elloso MM, Azrolan N, Sehgal SN, et al. Protective effect of the immunosuppressant sirolimus against aortic atherosclerosis in apo E-deficient mice. Am J Transplant 2003;3(5):562-569.
78. Bertz H, Laubenberger J, Steinfurth G, Finke J. Sinus venous thrombosis: an unusual cause for neurologic symptoms after bone marrow transplantation under immunosuppression. Transplantation 1998;66(2):241-244.
79. Zivkovic SA, Abu-Elmagd KM, Bond G, Eidelman BH. Long-term follow-up of neurologic complications of multivisceral and intestinal transplantation. Neurology 2005;64(Suppl 1):A123.
80. Pomeranz S, Naparstek E, Ashkenazi E, et al. Intracranial haematomas following bone marrow transplantation. J Neurol 1994;241(4):252-256.
81. Wijdicks EF, de Groen PC, Wiesner RH, Krom RA. Intracerebral hemorrhage in liver transplant recipients. Mayo Clin Proc 1995;70(5):443-446.
82. Wijdicks EF, Torres VE, Schievink WI, Sterioff S. Cerebral hemorrhage in recipients of renal transplantation. Mayo Clin Proc 1999;74(11):1111- 1112.
83. Rinaldi L, Busani S, Pasetto A, Girardis M. Posttransplant cerebral hemorrhage in a patient with familial amyloidotic polyneuropathy. Transplantation 2006;81(1):134-135.
84. Campbell JN, Morris PP. Cerebral vasculitis in graft-versus-host disease: a case report. AJNR Am J Neuroradiol 2005;26(3):654-656.
85. Gilden DH, Mahalingam R, Cohrs RJ, Kleinschmidt-DeMasters BK, Forghani B. The protean manifestations of varicella-zoster virus vasculopathy. J Neurovirol 2002;8(Suppl 2):75-79.
86. Wijdicks EF, Blue PR, Steers JL, Wiesner RH. Central pontine myelinolysis with stupor alone after orthotopic liver transplantation. Liver Transpl Surg 1996;2(1):14-16.
87. Buis CI, Wijdicks EF. Serial magnetic resonance imaging of central pontine myelinolysis. Liver Transpl 2002;8(7):643-645.
88. Yuh WT, Simonson TM, D'Alessandro MP, Smith KS, Hunsicker LG. Temporal changes of MR findings in central pontine myelinolysis. AJNR Am J Neuroradiol 1995;16(4 Suppl):975-977.
89. Estol CJ, Faris AA, Martinez AJ, Ahdab-Barmada M. Central pontine myelinolysis after liver transplantation. Neurology 1989;39(4):493-498.
90. Bleggi-Torres LF, de Medeiros BC, Ogasawara VS, et al. Iatrogenic Wernicke's encephalopathy in allogeneic bone marrow transplantation: a study of eight cases. Bone Marrow Transplant 1997;20(5):391-395.
91. Pagnan L, Berlot G, Pozzi-Mucelli RS. Magnetic resonance imaging in a case of Wernicke's encephalopathy. Eur Radiol 1998;8(6):977-980.
92. Loh Y, Watson WD, Verma A, Krapiva P. Restricted diffusion of the splenium in acute Wernicke's encephalopathy. J Neuroimaging 2005;15(4):373-375.
93. Pujol A, Pujol J, Graus F, et al. Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology 1993;43(1):65-69.
94. Lee J, Lacomis D, Comu S, Jacobsohn J, Kanal E. Acquired hepatocerebral degeneration: MR and pathologic findings. AJNR Am J Neuroradiol 1998;19(3):485-487.
95. Wijdicks EF, Plevak DJ, Rakela J, Wiesner RH. Clinical and radiologic features of cerebral edema in fulminant hepatic failure. Mayo Clin Proc 1995;70(2):119-124.
96. Schiff D, O'Neill B, Wijdicks E, Antin JH, Wen PY. Gliomas arising in organ transplant recipients: an unrecognized complication of transplantation? Neurology 2001;57(8):1486-1488.
97. Buell JF, Gross TG, Hanaway MJ, et al. Posttransplant lymphoproliferative disorder: significance of central nervous system involvement. Transplant Proc 2005;37(2):954-955.
98. Penn I, Porat G. Central nervous system lymphomas in organ allograft recipients. Transplantation 1995;59(2):240-244.
99. Pickhardt PJ, Wippold FJ 2nd. Neuroimaging in post-transplantation lymphoproliferative disorder. AJR Am J Roentgenol 1999;172(4):1117-1121.
100. Castellano-Sanchez AA, Li S, Qian J, Lagoo A, Weir E, Brat DJ. Primary central nervous system posttransplant lymphoproliferative disorders. Am J Clin Pathol 2004;121(2):246-253.
101. Gordon AR, Loevner LA, Sonners AI, Bolger WE, Wasik MA. Posttransplantation lymphoproliferative disorder of the paranasal sinuses mimicking invasive fungal sinusitis: case report. AJNR Am J Neuroradiol 2002;23(5):855-857.
102. Salvati M, Frati A, Caroli E, et al. Glioblastoma in kidney transplant recipients. Report of five cases. J Neurooncol 2003;63(1):33-37.
103. Penn I. Malignant melanoma in organ allograft recipients. Transplantation 1996;61(2):274-278.
104. Meyer MA. Elevated basal ganglia glucose metabolism in cyclosporine neurotoxicity: a positron emission tomography imaging study. J Neuroimaging 2002;12(1):92-93.
105. Sheth TN, Ichise M, Kucharczyk W. Brain perfusion imaging in asymptomatic patients receiving cyclosporin. AJNR Am J Neuroradiol 1999;20(5):853-856.
106. O'Conner AR, Franc BL. FDG PET imaging in the evaluation of post-transplant lymphoproliferative disorder following renal transplantation. Nucl Med Commun 2005;26(12):1107-1111.